Antithrombin III concentrates.
The general characteristics of antithrombin III (AT III) concentrates available in the United States are described in this article. The effectiveness of AT III concentrates in the prevention and treatment of thrombotic episodes in patients with hereditary AT III deficiency are summarized, and the use of this product in various conditions with acquired AT III deficiency are reported.
Menache
D
D
Plasma Derivatives Medical Services, American Red Cross National Headquarters, Washington, DC.
D000990:Antithrombin III / Q000008:administration & dosage / Q000302:isolation & purification / Q000493:pharmacokinetics / Q000627:therapeutic use*; D020152:Antithrombin III Deficiency; D002846:Chromatography, Affinity; D006801:Humans; D013927:Thrombosis / Q000188:drug therapy / Q000517:prevention & control*; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission
D000990:Antithrombin III